Clinical Trials Logo

Postpartum Smoking Relapse clinical trials

View clinical trials related to Postpartum Smoking Relapse.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT04098874 Recruiting - Clinical trials for Postpartum Smoking Relapse

Bupropion for the Prevention of Postpartum Smoking Relapse

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

This two-arm, double-blind, placebo-controlled randomized clinical trial will enroll pregnant women who quit smoking after learning they were pregnant and are motivated to stay abstinent postpartum. Participants will be randomized to receive extended-release bupropion (active 300mg or placebo once daily beginning 4 to 10 days postpartum to 12 weeks post-randomization). All participants will complete the same data collection procedures (e.g., biological sample collection for hormone and cotinine analysis and completion of validated questionnaires) at baseline (gestational week 36), weekly from 4 to 10 days postpartum through 12 weeks post-randomization and at weeks 12, 24, 36 and 52 post-randomization.